Antibiotics Active Pharmaceutical Ingredient (API) Market - Global Industry Analysis

Antibiotics Active Pharmaceutical Ingredient (API) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-6160 Status : Upcoming

Description

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Overview

Antibiotics API is the key ingredient in antibiotics sold in the market. There are different types of antibiotics API available in the market depending on the requirement of the pharmaceutical industry. API is the active ingredient that works against the infection which is why the demand for API is more all over the world.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Growth Factors

The global antibiotics active pharmaceutical ingredient (API) market is growing at a speedy rate. Factors such as an increase in outsourcing of drug discovery & development programs, an increase in the prevalence of bacterial infections, and an increase in sales of antibiotics are spurring the growth of the global market. Bacterial infections have a major impact on public health. They can be caused at any site of the body and are transmitted to humans through living vectors, food, water, and air. In addition to this, there is a rise in the number of healthcare-associated infections including ventilator-associated pneumonia, central line-associated bloodstream infections, and surgical site infections. As per the report of the Infectious Disease Society of America (IDSA), every year, around 2 million Americans develop hospital-acquired infections which lead to nearly 99,000 deaths. Thus, to overcome such a huge burden of disease, there is an increase in the uptake of antibiotics surge in the demand for more effective, advanced, and approved antibiotics API molecules all over the world which in turn is propelling the growth of the global antibiotics active pharmaceutical ingredient (API) market. In addition to this, the increase in efficient APIs suppliers to support the production of antibiotics is also one of the key factors that are escalating the growth of the market. Moreover, factors such as an increase in healthcare expenditure and an increase in initiatives of the government to reduce the mortality rate caused by the infectious disease are fueling the growth of the global market. Furthermore, an increase in R&D activities for the discovery of innovative drugs may offer several opportunities for the growth of the global antibiotics active pharmaceutical ingredient (API) market over the forecast period. However, economic & regulatory disincentives are making it difficult for businesses to develop new antibiotics which may hinder the growth of the global antibiotics active pharmaceutical ingredient (API) market.

With the current onset of the COVID-19 pandemic, many businesses around the world faced temporary shutdown due to strict lockdowns imposed by several governments. Halt on production activities and restrictions on international transport have led to a decline in the global economy. However, the increasing need for antibiotics to curb the spread of COVID-19 infection has positively influenced the growth of the global antibiotics active pharmaceutical ingredient (API) market. Though the antibiotics active pharmaceutical ingredient (API) market growth was affected to some extent during the pandemic period, it is expected to get back on track and register healthy growth over the forecast period.

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Segmentation

The global antibiotics active pharmaceutical ingredient (API) market is categorized based on API type, end-use, and region. Based on API type, the global antibiotics active pharmaceutical ingredient market is bifurcated into carbapenem antibiotics, cephalosporins, penicillin antibiotics, and others. The end-use segment comprises contract development & manufacturing organizations (CDMOs), contract manufacturing organizations (CMOs) and pharmaceutical companies.

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Regional Analysis

Asia Pacific is expected to dominate the global antibiotics active pharmaceutical ingredient (API) market. The region holds a large share of the market and China is expected to hold a major share of the market, presence of key API manufactures, and large demand of API from local pharmaceutical players contributing to the larger share of the market in the country. North America is anticipated to stay in the second position on the global antibiotic’s active pharmaceutical ingredient market in terms of market share. The primary factor that is supporting the growth of the market in the region includes a large number of antibiotics manufacturing pharmaceutical players and growing research on API synthesis. Europe is also expected to contribute significant revenue in the global antibiotics active pharmaceutical ingredient (API) market over the forecast period.

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Competitive Players

Due to the competitive nature of the market capital operation, mergers, integration, and acquisitions of small manufactures among large chemical API companies have become gradually frequent. Key players operating in the global antibiotics active pharmaceutical ingredient (API) market include Centrient Pharmaceuticals, Sandoz International GmbH, Nanjing Dorra Pharmaceutical Technology Co. Ltd., CordenPharma International, Parabolic Drugs Ltd., ACS DOBFAR SPA, DAEWOONG PHARMACEUTICAL CO. LTD., Penam Laboratories Ltd., Fresenius Kabi, ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD., and The United Laboratories International Holdings Limited, among others.

Global Antibiotics Active Pharmaceutical Ingredient (API) Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content


Frequently Asked Questions

Factors such as an increase in outsourcing of drug discovery & development programs, an increase in the prevalence of bacterial infections, and an increase in sales of antibiotics are spurring the growth of the global market. Furthermore, an increase in R&D activities for the discovery of innovative drugs may offer several opportunities for the growth of the global antibiotics active pharmaceutical ingredient (API) market over the forecast period.

Due to the competitive nature of the market capital operation, mergers, integration, and acquisitions of small manufactures among large chemical API companies have become gradually frequent. Key players operating in the global antibiotics active pharmaceutical ingredient (API) market include Centrient Pharmaceuticals, Sandoz International GmbH, Nanjing Dorra Pharmaceutical Technology Co. Ltd., CordenPharma International, Parabolic Drugs Ltd., ACS DOBFAR SPA, DAEWOONG PHARMACEUTICAL CO. LTD., Penam Laboratories Ltd., Fresenius Kabi, ASIATIC DRUGS & PHARMACEUTICALS PVT. LTD., and The United Laboratories International Holdings Limited, among others.

Asia Pacific is expected to dominate the global antibiotics active pharmaceutical ingredient (API) market. The region holds a large share of the market and China is expected to hold a major share of the market, presence of key API manufactures, and large demand of API from local pharmaceutical players contributing to the larger share of the market in the country.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social